Tocilizumab suppresses the pro-carcinogenic effects of breast cancer-associated fibroblasts through inhibition of the STAT3/AUF1 pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tocilizumab suppresses the pro-carcinogenic effects of breast cancer-associated fibroblasts through inhibition of the STAT3/AUF1 pathway
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 42, Issue 12, Pages 1439-1448
Publisher
Oxford University Press (OUP)
Online
2021-10-27
DOI
10.1093/carcin/bgab102
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of STAT3 signaling pathway in breast cancer
- (2020) Jia-hui Ma et al. Cell Communication and Signaling
- Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple‐negative breast cancer
- (2020) Noura N. Alraouji et al. MOLECULAR CARCINOGENESIS
- The tumor microenvironment
- (2020) Nicole M. Anderson et al. CURRENT BIOLOGY
- Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
- (2019) In-Hye Ham et al. Molecular Cancer
- Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance
- (2019) Micol Eleonora Fiori et al. Molecular Cancer
- The Tumor Microenvironment Innately Modulates Cancer Progression
- (2019) Dominique C. Hinshaw et al. CANCER RESEARCH
- IL-6 mediates cross-talk between activated fibroblasts and tumor cells in the tumor microenvironment
- (2018) Tatiana A Karakasheva et al. CANCER RESEARCH
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Potential pathophysiological pathways that can explain the positive effects of exercise on fatigue in multiple sclerosis: A scoping review
- (2017) Martin Langeskov-Christensen et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Trial of Tocilizumab in Giant-Cell Arteritis
- (2017) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Carcinoma-associated fibroblasts: orchestrating the composition of malignancy
- (2016) Philippe Gascard et al. GENES & DEVELOPMENT
- The inflammatory/cancer-related IL-6/STAT3/NF-κB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts
- (2016) Siti-Fauziah Hendrayani et al. Oncotarget
- Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go
- (2016) Rachel Buchsbaum et al. Cancers
- CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia
- (2015) F.-T. Liu et al. CLINICAL CANCER RESEARCH
- Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR−/HER2+breast cancers
- (2015) Ruth Rodriguez-Barrueco et al. GENES & DEVELOPMENT
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Versatile functions for IL-6 in metabolism and cancer
- (2015) Jan Mauer et al. TRENDS IN IMMUNOLOGY
- Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts
- (2015) Jean Albrengues et al. Nature Communications
- Curcumin Triggers p16-Dependent Senescence in Active Breast Cancer-Associated Fibroblasts and Suppresses Their Paracrine Procarcinogenic Effects
- (2015) Siti-Fauziah Hendrayani et al. NEOPLASIA
- Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
- (2014) Hermine I Brunner et al. ANNALS OF THE RHEUMATIC DISEASES
- The Cytokine IL-6 Reactivates Breast Stromal Fibroblasts through Transcription Factor STAT3-dependent Up-regulation of the RNA-binding Protein AUF1
- (2014) Siti-Fauziah Hendrayani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Pathological and Physiological Roles of IL-6 Amplifier Activation
- (2012) Masaaki Murakami et al. International Journal of Biological Sciences
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- p16INK4A Represses the paracrine tumor-promoting effects of breast stromal fibroblasts
- (2012) M M Al-Ansari et al. ONCOGENE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu
- (2010) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
- (2009) G. Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell Carcinoma
- (2009) S. Shinriki et al. CLINICAL CANCER RESEARCH
- IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
- (2008) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study
- (2008) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Breast Carcinoma-Associated Fibroblasts and Their Counterparts Display Neoplastic-Specific Changes
- (2008) N. M. Hawsawi et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started